Assistant Controller & Director Accounting
- Employer
- Assertio Therapeutics, Inc.
- Location
- Lake Forest, IL, United States
- Start date
- Feb 12, 2019
View more
- Discipline
- Administration, Accounting
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- BioMidwest
Job Details
ESSENTIAL JOB FUNCTIONS
• Leads the preparation of SEC reports
• Review calculations of significant / high risk estimates and/or unusual items
• Prepare technical accounting memos for unusual or complex matters
• Lead the development and monitoring of accounting policies and procedures
• Assist with system and software implementations as needed.
• Assist in managing relationship with internal and external auditors and organizing support, communicating company accounting decisions
• Assist in the preparation of quarterly financials for auditor review, including requested schedules.
• Work with the Controller to initiate, review, and implement process improvements across the department while maintaining the integrity and accuracy of the underlying accounting records.
• Assist with the development and implementation of internal controls and preparation of SOX 404 compliance.
• Be able to lead, manage and execute on special projects as needed, and across various functions.
• Ensure an accurate and timely monthly, quarterly and year end close; ensure the timely reporting of all monthly financial information.
• Perform or supervise month-end accounting activities such as reconciliations and journal entries.
• Collaborate with team members to ensure that the Accounting department is operating effectively by evaluating performance against goals, improving processes and systems where necessary, cross-training staff to mitigate dependencies and developing the team.
Requirements
EDUCATION AND EXPERIENCE
• Bachelor's degree with a major in Accounting or Finance is required.
• CPA required
• A minimum 8 years of experience in accounting, either at a publicly-traded company and/or auditing public companies.
• Previous experience managing finance and accounting functions;
• Previous experience with SEC filings for publicly trading companies;
• Previous experience with technical accounting matters and controls
• Demonstrated ability to work accurately and effectively with computerized data systems.
• Ability to work with people of diverse backgrounds and promote a positive working environment, spirit of cooperation and positive reactions to change and conflict resolution.
• Understanding of tax regulations and compliance;
About Us
THE COMPANY
Assertio Therapeutic is a leading specialty pharmaceutical company committed to putting the Patient First in everything we do; with a focus on enhancing the lives of patients, families, physicians, providers and in payors through commercialization of products in the areas of neurology, orphan and specialty therapies.
Assertio has a clear THREE PILLAR strategy for growth:
MAINTAIN a strong/profitable NUCYNTA franchise through a commercialization agreement with Collegium, GROW the Neurology Business and BUILD a new Specialty Business through a recent Cosyntropin transaction. The company's strategy is to continue to identify, license and develop new products-that offer enhanced therapeutic options to patient populations that may be underserved by existing therapies.
Assertio is an AA/EEO/Veterans/Disabled employer.
Company
Assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit. The Assertio mission of advancing patient care is reflected in our three-pillar strategy:
Maintain
Grow
Build
Maintain
In December 2017, the Company announced the signing of a definitive Commercialization Agreement with Collegium Pharmaceutical under which Collegium will commercialize the NUCYNTA pain franchise and Assertio will receive a royalty rate on all NUCYNTA revenues based on certain net sales thresholds.
Our long-term strategy is to continue to identify, license, develop and market distinctive products that offer enhanced therapeutic options for patients in need—all while maintaining the highest ethical standards in all our business practices.
We have developed and are licensing Acuform® technology, a patented oral delivery technology that allows for targeted, extended release of compounds into the upper GI tract. Acuform is currently utilized in four marketed products, including NUCYNTA ER and Gralise. To date, we’ve also licensed Acuform to six partners
Grow
We currently market three FDA-approved products for various neurological conditions.
Build
We have created a new specialty products business unit, with the objective of assembling a portfolio of specialty/orphan drugs that address the unmet needs of patients, physicians and payers. Our initial focus is the development of Cosyntropin (synthetic ACTH depot), a unique, late-stage product that, upon approval, will provide U.S. patients, physicians and payers with an alternative option.
NASDAQ: ASRT
- Website
- http://www.assertiotx.com/
- Phone
- 224-419-7106
- Location
-
100 South Saunders Road, Suite 300
Lake Forest
Illinois
60045
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert